GRAUER & WEIL | TATVA CHINTAN PHARMA | GRAUER & WEIL/ TATVA CHINTAN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 28.9 | 107.2 | 27.0% | View Chart |
P/BV | x | 5.8 | 2.6 | 224.6% | View Chart |
Dividend Yield | % | 0.5 | 0.2 | 197.5% |
GRAUER & WEIL TATVA CHINTAN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
GRAUER & WEIL Mar-24 |
TATVA CHINTAN PHARMA Mar-24 |
GRAUER & WEIL/ TATVA CHINTAN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 102 | 1,888 | 5.4% | |
Low | Rs | 49 | 1,063 | 4.6% | |
Sales per share (Unadj.) | Rs | 47.1 | 168.2 | 28.0% | |
Earnings per share (Unadj.) | Rs | 6.5 | 13.0 | 49.7% | |
Cash flow per share (Unadj.) | Rs | 7.4 | 23.9 | 30.9% | |
Dividends per share (Unadj.) | Rs | 0.50 | 2.00 | 25.0% | |
Avg Dividend yield | % | 0.7 | 0.1 | 487.4% | |
Book value per share (Unadj.) | Rs | 35.5 | 315.1 | 11.3% | |
Shares outstanding (eoy) | m | 226.71 | 23.39 | 969.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.6 | 8.8 | 18.3% | |
Avg P/E ratio | x | 11.7 | 113.7 | 10.3% | |
P/CF ratio (eoy) | x | 10.3 | 61.7 | 16.6% | |
Price / Book Value ratio | x | 2.1 | 4.7 | 45.5% | |
Dividend payout | % | 7.7 | 15.4 | 50.3% | |
Avg Mkt Cap | Rs m | 17,162 | 34,520 | 49.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,066 | 548 | 194.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 10,689 | 3,935 | 271.6% | |
Other income | Rs m | 335 | 75 | 446.4% | |
Total revenues | Rs m | 11,024 | 4,010 | 274.9% | |
Gross profit | Rs m | 1,886 | 684 | 275.7% | |
Depreciation | Rs m | 211 | 256 | 82.5% | |
Interest | Rs m | 48 | 67 | 70.9% | |
Profit before tax | Rs m | 1,962 | 436 | 450.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 499 | 132 | 378.0% | |
Profit after tax | Rs m | 1,463 | 304 | 481.9% | |
Gross profit margin | % | 17.6 | 17.4 | 101.5% | |
Effective tax rate | % | 25.5 | 30.3 | 83.9% | |
Net profit margin | % | 13.7 | 7.7 | 177.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 8,335 | 3,052 | 273.1% | |
Current liabilities | Rs m | 2,636 | 870 | 302.9% | |
Net working cap to sales | % | 53.3 | 55.5 | 96.1% | |
Current ratio | x | 3.2 | 3.5 | 90.1% | |
Inventory Days | Days | 28 | 14 | 200.4% | |
Debtors Days | Days | 634 | 65 | 979.0% | |
Net fixed assets | Rs m | 2,918 | 5,085 | 57.4% | |
Share capital | Rs m | 227 | 234 | 96.9% | |
"Free" reserves | Rs m | 7,825 | 7,137 | 109.6% | |
Net worth | Rs m | 8,052 | 7,371 | 109.2% | |
Long term debt | Rs m | 30 | 6 | 470.3% | |
Total assets | Rs m | 11,253 | 8,138 | 138.3% | |
Interest coverage | x | 42.1 | 7.5 | 563.9% | |
Debt to equity ratio | x | 0 | 0 | 430.5% | |
Sales to assets ratio | x | 0.9 | 0.5 | 196.4% | |
Return on assets | % | 13.4 | 4.6 | 294.6% | |
Return on equity | % | 18.2 | 4.1 | 441.1% | |
Return on capital | % | 24.9 | 6.8 | 364.8% | |
Exports to sales | % | 5.4 | 73.1 | 7.4% | |
Imports to sales | % | 9.0 | 18.3 | 48.8% | |
Exports (fob) | Rs m | 575 | 2,876 | 20.0% | |
Imports (cif) | Rs m | 957 | 722 | 132.5% | |
Fx inflow | Rs m | 575 | 2,876 | 20.0% | |
Fx outflow | Rs m | 987 | 722 | 136.6% | |
Net fx | Rs m | -411 | 2,154 | -19.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,591 | 980 | 162.3% | |
From Investments | Rs m | -1,082 | -1,205 | 89.7% | |
From Financial Activity | Rs m | -202 | 305 | -66.3% | |
Net Cashflow | Rs m | 307 | 79 | 386.6% |
Indian Promoters | % | 69.0 | 72.0 | 95.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.0 | 10.2 | 9.8% | |
FIIs | % | 1.0 | 3.3 | 28.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 31.0 | 28.0 | 110.7% | |
Shareholders | 60,540 | 79,623 | 76.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare GRAUER & WEIL With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES NAVIN FLUORINE
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | GRAUER & WEIL | TATVA CHINTAN PHARMA |
---|---|---|
1-Day | -0.10% | -2.70% |
1-Month | -12.84% | -16.54% |
1-Year | 70.83% | -45.71% |
3-Year CAGR | 49.11% | -32.12% |
5-Year CAGR | 33.58% | -18.97% |
* Compound Annual Growth Rate
Here are more details on the GRAUER & WEIL share price and the TATVA CHINTAN PHARMA share price.
Moving on to shareholding structures...
The promoters of GRAUER & WEIL hold a 69.0% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GRAUER & WEIL and the shareholding pattern of TATVA CHINTAN PHARMA.
Finally, a word on dividends...
In the most recent financial year, GRAUER & WEIL paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 7.7%.
TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 15.4%.
You may visit here to review the dividend history of GRAUER & WEIL, and the dividend history of TATVA CHINTAN PHARMA.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.